Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network

Deenan Pillay; Jan Deenan; Silvia Bertagnolio; Charles Boucher; Francoise Brun-Vezinet; Bonaventura Clotet; Carlo Giaquinto; Carlo F. Perno

doi:10.3851/IMP2650

Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network

Deenan Pillay, Jan Deenan, Silvia Bertagnolio, Charles Boucher, Francoise Brun-Vezinet, Bonaventura Clotet, Carlo Giaquinto, Carlo F. Perno

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

Research output: Contribution to journal › Article › peer-review

Abstract

Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission.

Original language	English
Pages (from-to)	831-836
Number of pages	6
Journal	Antiviral Therapy
Volume	18
Issue number	6
DOIs	https://doi.org/10.3851/IMP2650
Publication status	Published - 2013

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)
Infectious Diseases
Medicine(all)

Access to Document

10.3851/IMP2650

Cite this

Pillay, D., Deenan, J., Bertagnolio, S., Boucher, C., Brun-Vezinet, F., Clotet, B., Giaquinto, C., & Perno, C. F. (2013). Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network. Antiviral Therapy, 18(6), 831-836. https://doi.org/10.3851/IMP2650

Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings : Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network. / Pillay, Deenan; Deenan, Jan; Bertagnolio, Silvia et al.

In: Antiviral Therapy, Vol. 18, No. 6, 2013, p. 831-836.

Research output: Contribution to journal › Article › peer-review

Pillay, D, Deenan, J, Bertagnolio, S, Boucher, C, Brun-Vezinet, F, Clotet, B, Giaquinto, C & Perno, CF 2013, 'Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network', Antiviral Therapy, vol. 18, no. 6, pp. 831-836. https://doi.org/10.3851/IMP2650

@article{f2063f024c0a4806960858b1f37807eb,

title = "Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network",

abstract = "Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission.",

author = "Deenan Pillay and Jan Deenan and Silvia Bertagnolio and Charles Boucher and Francoise Brun-Vezinet and Bonaventura Clotet and Carlo Giaquinto and Perno, {Carlo F.}",

year = "2013",

doi = "10.3851/IMP2650",

language = "English",

volume = "18",

pages = "831--836",

journal = "Antiviral Therapy",

issn = "1359-6535",

publisher = "International Medical Press Ltd",

number = "6",

}

TY - JOUR

T1 - Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings

T2 - Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network

AU - Pillay, Deenan

AU - Deenan, Jan

AU - Bertagnolio, Silvia

AU - Boucher, Charles

AU - Brun-Vezinet, Francoise

AU - Clotet, Bonaventura

AU - Giaquinto, Carlo

AU - Perno, Carlo F.

PY - 2013

Y1 - 2013

N2 - Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission.

AB - Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission.

UR - http://www.scopus.com/inward/record.url?scp=84890364624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890364624&partnerID=8YFLogxK

U2 - 10.3851/IMP2650

DO - 10.3851/IMP2650

M3 - Article

C2 - 23740717

AN - SCOPUS:84890364624

VL - 18

SP - 831

EP - 836

JO - Antiviral Therapy

JF - Antiviral Therapy

SN - 1359-6535

IS - 6

ER -

Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this